factual

Rise of non-inferiority trials signals picked low-hanging fruit

Many trials in top journals today are non-inferiority trials—comparing a new therapy to an accepted one merely to show it is not worse, justified by advantages like better tolerability or less invasiveness rather than greater efficacy or lower cost—which signals that medicine has already captured its large breakthroughs and now mostly produces small incremental advances.

factualpending

Speaker

Adam Cifu

Evidence Quote

“many of the trials these days are not inferiority trials”

Source

Adam Cifu on the Case for Being a Medical Conservative— EconTalk
Created: 6/13/2026, 12:18:13 AM

Your notes

Loading notes...